Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in...
Please note: I'm just sharing my view. its not a recommendation for buying or selling.
...Close don't cut it though
TERRIBLE decision to sell, absolutely TERRIBLE!!! And I knew it immediately after too! Still a good alert though
Bad idea. Should have cut earlier
I said to myself I would buy only at $1.00. I've been watching this for awhile now. Short term swing
Wait for 1 dollar or nothing at all
Similar to the IGC play. Has some followers, and there hasn't been any news for awhile. 1/2 entry
www.marketwatch.com finance.yahoo.com www.marketwatch.com seekingalpha.com
If you are not familiar with the Stock, get to know it now, it has made investors a lot of money in the past 4 trading days, tripling in value. There is always concerns when it comes to such low cap companies but this rally is based on facts not speculation. After a extremely upbeat drug trial report it was upgraded to $12 the following day by Oppenheimer. There...